Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane
2. 1,1,1,2,2,3,4,5,5,5-decafluoropentane
3. 1,1,1,2,3,4,4,5,5,5-decafluoropentane
4. 2,3-dihydroperfluoropentane
5. 2h,3h-perfluoropentane
6. Echogen
7. Nvx-108
8. Perflenapent
9. Perfluoropentane
1. Perflenapent
2. Perfluoropentane
3. 678-26-2
4. Perfluoro-n-pentane
5. Pentane, Dodecafluoro-
6. Nvx-108
7. N-perfluoropentane
8. 483au1y5cz
9. Chebi:39428
10. Perfluoropentane; Dodecafluoropentane
11. 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane
12. Perfuoro-n-pentane
13. Ncgc00167420-01
14. Flutec Pp50
15. Perflenapent [usan]
16. Mfcd00042081
17. Einecs 211-647-5
18. Perflenapent [usan:inn]
19. Brn 1712388
20. Perflenapentum
21. Unii-483au1y5cz
22. Dodecafluoro-pentane
23. R 41(12)
24. Fluorinert Fc 87
25. Fluorinertr(fc-87)
26. Dodecafluoro-n-pentane
27. Dodecafluoropentane(s)
28. Flutec Pp 50
29. Perfluoropentane 99%
30. Fluorinert Pf 5050
31. Perflenapent (usan/inn)
32. Perflenapent [inn]
33. Dsstox_cid_26613
34. Dsstox_rid_81766
35. Dsstox_gsid_46613
36. Schembl33962
37. Perflenapent [mart.]
38. 4-01-00-00308 (beilstein Handbook Reference)
39. Perflenapent [who-dd]
40. Chembl1899801
41. Dtxsid3046613
42. Nvx 108
43. Fc 87
44. Moli000988
45. Zinc8214647
46. Tox21_112424
47. Dodecafluoropentane [ema Epar]
48. Akos025310445
49. Db11625
50. Fc 4112
51. Cas-678-26-2
52. D05436
53. A835897
54. Q7168152
55. W-109591
56. 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane #
57. Pentane, 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoro-
58. 1,1,1,2,2,3,3,4,4,5,5,5-dodecakis(fluoranyl)pentane
| Molecular Weight | 288.03 g/mol |
|---|---|
| Molecular Formula | C5F12 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 2 |
| Exact Mass | 287.9808379 g/mol |
| Monoisotopic Mass | 287.9808379 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 250 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
EchoGen is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left ventricular border delineation with resulting improvement in wall motion visualisation.
EchoGen should only be used in patients where the study without contrast enhancement is inconclusive.
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V08DA
V - Various
V08 - Contrast media
V08D - Ultrasound contrast media
V08DA - Ultrasound contrast media
V08DA03 - Perflenapent
ABOUT THIS PAGE
17
PharmaCompass offers a list of Dodecafluoropentane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dodecafluoropentane manufacturer or Dodecafluoropentane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dodecafluoropentane manufacturer or Dodecafluoropentane supplier.
PharmaCompass also assists you with knowing the Dodecafluoropentane API Price utilized in the formulation of products. Dodecafluoropentane API Price is not always fixed or binding as the Dodecafluoropentane Price is obtained through a variety of data sources. The Dodecafluoropentane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dodecafluoropentane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dodecafluoropentane, including repackagers and relabelers. The FDA regulates Dodecafluoropentane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dodecafluoropentane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dodecafluoropentane supplier is an individual or a company that provides Dodecafluoropentane active pharmaceutical ingredient (API) or Dodecafluoropentane finished formulations upon request. The Dodecafluoropentane suppliers may include Dodecafluoropentane API manufacturers, exporters, distributors and traders.
Dodecafluoropentane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dodecafluoropentane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dodecafluoropentane GMP manufacturer or Dodecafluoropentane GMP API supplier for your needs.
A Dodecafluoropentane CoA (Certificate of Analysis) is a formal document that attests to Dodecafluoropentane's compliance with Dodecafluoropentane specifications and serves as a tool for batch-level quality control.
Dodecafluoropentane CoA mostly includes findings from lab analyses of a specific batch. For each Dodecafluoropentane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dodecafluoropentane may be tested according to a variety of international standards, such as European Pharmacopoeia (Dodecafluoropentane EP), Dodecafluoropentane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dodecafluoropentane USP).
